SalioGen Therapeutics Appoints Kali Stasi, M.D., Ph.D. as Chief Medical Officer

Posted on by

-Dr. Stasi brings to SalioGen 30 years of experience in ophthalmology and genetic medicine- LEXINGTON, Mass., Aug. 19, 2024 /PRNewswire/ — SalioGen Therapeutics, a biotechnology company developing next-generation genetic medicines based on its novel Gene Coding™ technology, today…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.